Τετάρτη 23 Δεκεμβρίου 2015

Impressive Results With Daratumumab Plus Lenalidomide/Dexamethasone in Multiple Myeloma

The anti-CD38 monoclonal antibody daratumu­mab (Darzalex) took center stage among multiple myeloma studies presented at the 57th American Society of Hematology Annual Meeting and Exposition. In relapsed/refra

from Cancer via ola Kala on Inoreader http://ift.tt/1NN180d
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου